Study of Natural Cytotoxicity Receptors in Patients with HIV/AIDS and Cancer: A Cross-Sectional Study

Table 1

Baseline Characteristics from subjects in different groups.

	Number of females/males	Age in years	Days since HIV/AIDS diagnosis	Viral load HIV RNA/mL (range)	CD4/CD8 ratio	HAART treated	Days since cancer diagnosis
Healthy donors	1/24	43 (20–65)	NA	NA	NA	NA	NA
HIV/AIDS	5/20	45 (19–69)	4437 (419–9267)	(<40–512.000)	0.71 (0.11–1.57)	Yes	NA
HIV/AIDSWC	4/17	45 (30–69)	2628 (88–8679)	(<40–113.000)	0.40 (0.04–1.35)	Yes	1800 (40–7488)

The median (range) for each group is shown. Only the range for each group is shown. The HIV/AIDSWC group had eight patients with viral load classified as “undetectable.” The HIV/AIDS group had eighteen patients with viral load classified as “undetectable.” These patients are not included in the table. NA: not applicable.